18 patents
Utility
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
28 Sep 23
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 30 May 23
Utility
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
21 Sep 23
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 30 May 23
Utility
Ophthalmic compositions for treating ocular
12 Sep 23
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 26 Jul 22
Utility
Systemic Isoxazoline Parasiticides for Vector-borne and Viral Disease Treatment or Prophylaxis
13 Jul 23
Disclosed herein are methods of treating or preventing vector-borne diseases including Lyme disease via delivery of one, two, or more systemic doses of an isoxazoline anti-parasitic therapeutic agent to an individual with confirmed or suspected infestation of Lyme disease.
Bobak Robert Azamian, Douglas Michael Ackermann, Christopher William Stivers, Shawn D. Hickok
Filed: 15 Mar 23
Utility
Methods for treating ocular
4 Jul 23
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 26 Jul 22
Utility
Methods for treating demodex blepharitis using lotilaner formulations
4 Jul 23
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 26 Jul 22
Utility
Methods for Treating Ocular Demodex Using Spinosad Formulations
17 Nov 22
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 26 Jul 22
Utility
Methods for Treating Ocular Demodex Using Spinosad Formulations
10 Nov 22
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 26 Jul 22
Utility
Methods for Treating Ocular Demodex Using Spinosad Formulations
10 Nov 22
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 26 Jul 22
Utility
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
11 Aug 22
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 19 Jun 19
Utility
Systemic Isoxazoline Parasiticides for Vector-borne and Viral Disease Treatment or Prophylaxis
26 May 22
Disclosed herein are methods of treating or preventing infections associated with organisms, or preventing vector-borne diseases including Plasmodium infestation and/or malaria via delivery of one, two, or more systemic doses of an isoxazoline anti-parasitic therapeutic agent to an individual with confirmed or suspected infestation of Plasmodium and/or malaria.
Bobak Robert Azamian, Douglas Michael Ackermann, Christopher William Stivers, Shawn D. Hickok
Filed: 3 Apr 20
Utility
Pharmaceutical Compositions for Demodex Related Blepharitis and Eyelid Crusting
28 Apr 22
Formulation of ectoparasiticidal and antibiotic “compositions into pharmaceutical compositions useful for the treatment of eyelid inflammation, in particular demodex related blepharitis and eye crusting.
Tiang Hin Jerry Tan, Yong Ming POR
Filed: 7 Jan 22
Utility
RepublicationMethods for Treating Ocular Demodex Using Spinosad Formulations
24 Feb 22
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 16 Nov 20
Utility
Isoxazoline parasiticide formulations and methods for treating blepharitis
14 Dec 21
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 5 Mar 21
Utility
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
1 Jul 21
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 5 Mar 21
Utility
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
18 Mar 21
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 16 Nov 20
Utility
Isoxazoline Parasiticide Formulations and Methods for Treating Blepharitis
18 Mar 21
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 16 Nov 20
Utility
Methods for treating ocular demodex using isoxazoline parasiticide formulations
16 Nov 20
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis.
Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
Filed: 13 Dec 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first